We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Blood Tests Improve Hypertension Treatment

By LabMedica International staff writers
Posted on 17 May 2017
Print article
African and African American hypertensives tend to retain salt and water, with lower levels of plasma renin and more resistant hypertension. Two simple blood tests were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.

By testing patients' levels of plasma renin, a protein secreted by the kidneys, in combination with levels of aldosterone, a hormone that causes salt and water retention, physicians were able to identify the physiological changes causing the hypertension. This led to personalized and more accurate therapy.

An international team of scientists under the auspices of Western University enrolled patients at hypertension clinics in Nigeria, Kenya, and South Africa with a systolic blood pressure greater than140 mm Hg or diastolic pressure greater than 90 mm Hg despite treatment were allocated to usual care (UC) versus physiologically individualized care (PhysRx). Plasma renin activity and aldosterone were measured using enzyme-linked immunosorbent assay (ELISA) kits. Patients were followed for one year; the primary outcome was the percentage of patients achieving blood pressure less than140 mm Hg and diastolic less than 90 mm Hg.

Of the 94 patients who completed the study, 42 were treated with the usual course of treatment, 52 were given the blood tests, and treatment was decided based on the results. In the group who were given usual treatment, 11.1% had controlled blood pressure after one year, versus 50% in the group that received the blood test. Systolic control was achieved in 13.9% of UC versus 60.3% of PhysRx; diastolic control in 36.1% of UC versus 67.2% of PhysRx.

The authors concluded that physiologically individualized therapy based on renin/aldosterone phenotyping significantly improved blood pressure control in a sample of African patients with uncontrolled hypertension. This approach should be tested in African American and other patients with resistant hypertension. J. David Spence, MBA, MD, FRCPC, a professor and lead investigator of the study said, “"If a patient has salt and water retention, it causes high blood pressure and also feeds back and shuts down both renin and aldosterone.” The study was published on May 2, 2017, in the American Journal of Hypertension.

New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
PROM Test
AMNIOQUICK DUO
New
Gold Member
Legionella Pneumophila Test
Legionella Pneumophila ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.